Jitendra Jonnagaddala
Overview
Explore the profile of Jitendra Jonnagaddala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
1814
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nasca V, Zhao J, Ros J, Lonardi S, Zwart K, Cohen R, et al.
J Immunother Cancer
. 2025 Feb;
13(2).
PMID: 39929672
Background: Immune checkpoint inhibitors (ICIs) are the gold standard therapy in patients with deficient mismatch repair (dMMR)/microsatellite instability-high (MSI-H) metastatic colorectal cancer (mCRC). A significant proportion of patients show resistance,...
2.
Jonnagaddala J, Ahmed S, Chayeb J
Clin Res Hepatol Gastroenterol
. 2025 Jan;
49(3):102536.
PMID: 39864544
Gastrointestinal bleeding; Colonic varices; Lower gastrointestinal bleeding.
3.
4.
Gupta S, Liu J, Wong Z, Jonnagaddala J
Stud Health Technol Inform
. 2024 Aug;
316:719-723.
PMID: 39176896
Automatic deidentification of Electronic Health Records (EHR) is a crucial step in secondary usage for biomedical research. This study introduces evaluation of an intricate hybrid deidentification strategy to enhance patient...
5.
Lukitasari M, Jonnagaddala J, Liaw S, Jalaludin B
Stud Health Technol Inform
. 2024 Aug;
316:349-353.
PMID: 39176745
Visit-to-visit blood pressure variability (BPV) is associated with cardiovascular disease (CVD) and its mortality, independent of mean blood pressure (BP). However, in real world clinical practice this phenomenon is under-appreciated...
6.
Rakhshanda S, Liaw S, Rhee J, Rye K, Jonnagaddala J
Stud Health Technol Inform
. 2024 Aug;
316:132-136.
PMID: 39176691
Statins are a group of medications that lower lipid and are used for primary and secondary prevention of cardiovascular diseases (CVD). Patients can either be partially (15%) or completely (5%)...
7.
Lukitasari M, Jonnagaddala J, Liaw S, Jalaludin B
Stud Health Technol Inform
. 2024 Jul;
315:262-266.
PMID: 39049265
Visit-to-visit (VVV) blood pressure variability (BPV) is associated with cardiovascular disease. However, in practice, BPV at sequential clinic visits is often regarded as mere random fluctuations and frequently under-appreciated by...
8.
Hossain F, Muscatello D, Jayasinghe S, Jonnagaddala J, Liu B
Vaccine
. 2024 Apr;
42(12):3084-3090.
PMID: 38584056
Background: In 2020 Australia changed the funded universal older adult pneumococcal vaccination program from use of the 23-valent pneumococcal polysaccharide vaccine (PPV23) at age 65 to the 13-valent pneumococcal conjugate...
9.
Lukitasari M, Liaw S, Jalaludin B, Jonnagaddala J
Stud Health Technol Inform
. 2024 Jan;
310:1358-1359.
PMID: 38270042
Visit-to-visit blood pressure variability (BPV) is associated with cardiovascular disease (CVD), independently of mean blood pressure (BP). However, in real world clinical practice, this phenomenon is frequently considered as random...
10.
Rakhshanda S, Liaw S, Rhee J, Rye K, Jonnagaddala J
Stud Health Technol Inform
. 2024 Jan;
310:986-990.
PMID: 38269962
Statin is a group of lipid/cholesterol-lowering medications that is commonly used for primary and secondary prevention of cardiovascular diseases (CVD). In Australia, this is the first line of pharmacological therapy...